NSCI vs. OBI, SNG, DEST, OPTI, SBTX, ONC, HEMO, BVX, IMM, and GENF
Should you be buying NetScientific stock or one of its competitors? The main competitors of NetScientific include Ondine Biomedical (OBI), Synairgen (SNG), Destiny Pharma (DEST), OptiBiotix Health (OPTI), SkinBioTherapeutics (SBTX), Oncimmune (ONC), Hemogenyx Pharmaceuticals (HEMO), BiVictriX Therapeutics (BVX), ImmuPharma (IMM), and Genflow Biosciences (GENF). These companies are all part of the "biotechnology" industry.
Ondine Biomedical (LON:OBI) and NetScientific (LON:NSCI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, community ranking, institutional ownership, media sentiment, dividends, risk, analyst recommendations, earnings and valuation.
NetScientific has higher revenue and earnings than Ondine Biomedical. NetScientific is trading at a lower price-to-earnings ratio than Ondine Biomedical, indicating that it is currently the more affordable of the two stocks.
Ondine Biomedical has a net margin of 0.00% compared to Ondine Biomedical's net margin of -221.55%. Ondine Biomedical's return on equity of -21.43% beat NetScientific's return on equity.
7.5% of Ondine Biomedical shares are owned by institutional investors. Comparatively, 4.3% of NetScientific shares are owned by institutional investors. 50.0% of Ondine Biomedical shares are owned by company insiders. Comparatively, 40.0% of NetScientific shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Ondine Biomedical has a beta of -0.01, suggesting that its stock price is 101% less volatile than the S&P 500. Comparatively, NetScientific has a beta of 1.46, suggesting that its stock price is 46% more volatile than the S&P 500.
In the previous week, NetScientific had 1 more articles in the media than Ondine Biomedical. MarketBeat recorded 1 mentions for NetScientific and 0 mentions for Ondine Biomedical. NetScientific's average media sentiment score of 0.00 equaled Ondine Biomedical'saverage media sentiment score.
NetScientific received 70 more outperform votes than Ondine Biomedical when rated by MarketBeat users. However, 100.00% of users gave Ondine Biomedical an outperform vote while only 69.61% of users gave NetScientific an outperform vote.
Summary
Ondine Biomedical and NetScientific tied by winning 7 of the 14 factors compared between the two stocks.
Get NetScientific News Delivered to You Automatically
Sign up to receive the latest news and ratings for NSCI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NSCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
NetScientific Competitors List
Related Companies and Tools
